1 31/12/2023 2023-12-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-01-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 7803491 2023-01-01 2023-12-31 7803491 2023-12-31 7803491 2022-01-01 2022-12-31 7803491 2022-12-31 7803491 bus:Director1 2023-01-01 2023-12-31 7803491 core:WithinOneYear 2023-12-31 7803491 core:WithinOneYear 2022-12-31 7803491 bus:Director1 2022-12-31 7803491 bus:Director1 2023-12-31 7803491 bus:Director1 2021-12-31 7803491 bus:Director1 2022-12-31 7803491 bus:Director1 2022-01-01 2022-12-31 7803491 bus:Micro-entities 2023-01-01 2023-12-31 7803491 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 7803491 bus:FullAccounts 2023-01-01 2023-12-31 7803491 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 7803491 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31
Company registration number: 7803491
ANNALEE MEDICAL COMMUNICATIONS LTD
Unaudited filleted financial statements
31 December 2023
ANNALEE MEDICAL COMMUNICATIONS LTD
Statement of financial position
31 December 2023
2023 2022
£ £
Fixed assets 755 1,007
_______ _______
Current assets 276,209 247,502
Creditors: amounts falling due within one year ( 25,614) ( 18,293)
_______ _______
Net current assets 250,595 229,209
_______ _______
Total assets less current liabilities 251,350 230,216
Accruals and deferred income ( 1,260) ( 1,170)
_______ _______
Net assets 250,090 229,046
_______ _______
Capital and reserves 250,090 229,046
_______ _______
Notes to the financial statements
ANNALEE MEDICAL COMMUNICATIONS LTD
Year ended 31 December 2023
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
2. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2023
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Dr Louise Brady ( 355) ( 5,330) - ( 5,685)
_______ _______ _______ _______
2022
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Dr Louise Brady ( 1,538) ( 355) 1,538 ( 355)
_______ _______ _______ _______
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 25 January 2024 , and are signed on behalf of the board by:
Dr Louise Brady
Director
Company registration number: 7803491
The company is a private company limited by shares, registered in England and Wales.